Company news

BioCardia, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

BioCardia Announces European Patent Office Decision to Grant Patent on Autologous Cell Therapy Patient Selection Diagnostic Assay

June 20, 2021

BioCardia Reports First Quarter 2021 Financial Results and Business Highlights

May 12, 2021

BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates

April 25, 2021

BioCardia Reports 2020 Financial Results and Recent Business Highlights

March 29, 2021

BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates

February 22, 2021

BioCardia Announces Clinical Leadership Changes

February 16, 2021

BioCardia Update on Cell Therapy Product Development and 2021 Milestones

February 1, 2021

Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia’s Board of Directors

January 10, 2021

BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies

December 29, 2020

BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed

December 16, 2020

BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

December 15, 2020

BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

December 13, 2020

BioCardia Reports Third Quarter 2020 Financial Results and Business Highlights

November 9, 2020

BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights

August 12, 2020

BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020

August 6, 2020

BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era

June 30, 2020

BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial Ischemia

June 30, 2020

BioCardia Announces Pricing of $10 Million Public Offering

June 16, 2020

BioCardia Reports First Quarter 2020 Financial Results and Business Highlights

May 14, 2020

BioCardia Announces Positive Preclinical Results Supporting Investigational New Drug Application for Anti-Inflammatory Cell Therapy in Heart Failure

May 4, 2020

Biocardia Announces FDA-Recommended Modifications to Primary Endpoint for Cardiamp Cell Therapy Heart Failure Trial to Support Marketing Approval

April 29, 2020

BioCardia Awarded New U.S. Patent Covering Helix System for Local Biotherapeutic Delivery of Autologous and Allogenic Cells to the Heart

April 27, 2020

BioCardia Announces Litigation Financing in the Case Captioned Boston Scientific Corp., et al., v. BioCardia Inc.

April 13, 2020

BioCardia reports 2019 financial results and recent business highlights

April 8, 2020

BioCardia announces positive DSMB recommendation to continue phase iii pivotal CardiAMP heart failure study, as planned

March 30, 2020

BioCardia announces timing for prespecified data safety monitoring board report on pivotal CardiAMP heart failure trial

March 11, 2020

Biocardia Announces FDA Clearance for Morph DNA Deflectable Guide Catheter

January 13, 2020

BioCardia Announces New U.S. Patent Covering CardiAMP Cell Therapy and Issuance of Two Asian Patents Covering Radial Artery Approach for Cardiac Cell and Gene Therapy Delivery

January 7, 2020

BioCardia Reports 2019 Third Quarter Financial Results and Business Highlights

November 18, 2019

BioCardia Receives CE Mark Renewal For Helix Biotherapeutic Delivery Catheter And Morph Guide Catheter Through May 2024

October 7, 2019

BioCardia Announces the Appointment of Two New Board Members

October 1, 2019

BioCardia Initiates Commercial Release of AVANCE Steerable Introducer Designed to Enhance Physician Control for Complex Cardiac Procedures

September 30, 2019

BioCardia Announces Positive DSMB Recommendation to Continue Phase 3 Pivotal CardiAMP Heart Failure Study as Planned

September 15, 2019

← Newer news releases

Calls

The 5 newest of 19 calls. Every call is listed under its year.

Decks

The 5 newest of 13 decks. Every deck is listed under its year.